The increase in price target by Barclays reflects a positive outlook on Quest Diagnostics, likely due to improved financial performance or market conditions. This adjustment suggests that Barclays sees more value in the stock than previously, which could lead to increased investor confidence and potentially drive the stock price up in the short term.